Details of the Drug Formulations

General Information of Drug (ID: DM26IH8)

Drug Name
S-297995 Drug Info
Synonyms
NALDEMEDINE; UNII-03KSI6WLXH; 03KSI6WLXH; S-297,995; 916072-89-4; Naldemedine [USAN:INN]; Naldemedine (USAN/INN); S 297995; SCHEMBL9880572; GTPL9150; CHEMBL2105755; AKOS032945757; DB11691; Morphinan-7-carboxamide, 17-(cyclopropylmethyl)-6,7-didehydro-4,5-epoxy-3,6,14- trihydroxy-N-(1-methyl-1-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl)-,(5alpha)-; J3.573.009E; D10188
Indication
Disease Entry ICD 11 Status REF
Opioid dependence 6C43.2Z Phase 2 [1]
Cross-matching ID
PubChem CID
54732242
CAS Number
916072-89-4
TTD ID
D0Q3PD
ACDINA ID
D00453

Full List of Drug Formulations Containing This Drug

Naldemedine 0.2 mg tablet
Company Formulation ID FDA Description
Purdue Pharma F14851 Magnesium stearate; Mannitol; Ferric oxide yellow; Talc; Croscarmellose sodium; Hypromellose, unspecified
------------------------------------------------------------------------------------
Naldemedine Tosylate 0.2mg tablet
Company Formulation ID FDA Description
Biodelivery Sciences International F23350 D-Mannitol; Croscarmellose Sodium; Magnesium Stearate; Hypromellose; Talc; Yellow Ferric Oxide
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of Shionogi (2011).